Apoptosis Assay Market Trends, Demand, Share & Size 2022-27 According to IMARC Group’s latest report, titled “Apoptosis Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global apoptosis assay market is expected to exhibit a CAGR of 8.87% during 2022-2027. Apoptosis assays are utilized by researchers to detect cellular and biochemical events associated with programmed cell death. They offer in-depth insights into small molecule and biological drugs, cell death mechanisms, functions of the immune system at the molecular level, etc. Currently, a significant rise in the incidences of cancer has increased the adoption of apoptosis assays to understand the effects of chemotherapy and gene drugs in both in vivo and in vitro conditions. Apoptosis assays determine the sensitivity of given cancer cells to a specific medicine and aid in developing a therapeutic strategy accordingly.
Request for a PDF sample of this report: https://www.imarcgroup.com/apoptosis-assay-market/requestsample
The extensive adoption of clinical cytotoxic and cytoprotective agents in treating cancer, ischemic diseases, neurodegenerative diseases, etc., is driving the apoptosis assay market. Furthermore, real-time and live-cell assays are gaining traction with numerous other methods to monitor apoptotic events over time. Moreover, the growing focus on extensive research and development on therapeutic drugs is also catalyzing the market growth. Additionally, various pharmaceutical manufacturers are launching innovative and economical assay kits, instruments, reagents, etc., which is contributing to the market growth. Besides this, several researchers have discovered that the coronavirus infection (COVID-19) triggers cell apoptosis and inflammatory cytokine processing in the lung cells and activates caspase-8. This, in turn, is expected to expand the applications of apoptosis assays in the coming years. Looking forward, IMARC Group expects the global apoptosis assay market to continue its robust growth during the forecast period (2022-2027).
Checkout Now: https://www.imarcgroup.com/checkout?id=3645&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
- Abcam plc
- Agilent Technologies Inc.
- Becton Dickinson and Company
- Bio-Rad Laboratories Inc.
- Bio-Techne Corporation
- Merck KGaA
- PerkinElmer Inc.
- Promega Corporation
- Sartorius Aktiengesellschaft
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
Market Segmentation:
Breakup by Product:
- Kits
- Reagents
- Instruments
- Others
Breakup by Technique:
- Flow Cytometry
- Fluorescence Microscopy
- Spectrophotometry
- Others
Breakup by Assay Type:
- Caspase Assay
- DNA Fragmentation Assay
- Cell Permeability Assay
- Mitochondrial Assay
Breakup by End Use:
- Pharmaceutical and Biotechnology Companies
- Hospital and Diagnostic Laboratories
- Academic and Research Institutes
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/apoptosis-assay-market
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
Digital Health Market: https://www.imarcgroup.com/digital-health-market
Pharmacy Automation Market: https://www.imarcgroup.com/pharmacy-automation-market
Cell Analysis Market: https://www.imarcgroup.com/cell-analysis-market
Organic and Natural Pet Food Market: https://www.imarcgroup.com/organic-natural-pet-food-market
Angioplasty Balloons Market: https://www.imarcgroup.com/angioplasty-balloons-market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800